Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

NCT04082286 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloblastic Leukemia
Acute Lymphoblastic Leukemia
Juvenile Myelomonocytic Leukemia

Interventions

OTHER: Yttrium-90 labelled monoclonal antibody against CD66

Sponsor

Great Ormond Street Hospital for Children NHS Foundation Trust